Every year, 15 February is accepted as International Childhood Cancer Day in order to raise awareness and emphasise this point for individuals diagnosed with cancer in childhood. Leukaemia, also known as blood cancer, is one of the most common types of cancer in children.
Carrying out studies within our Molecular Biology, Genetics and Protein R&D Laboratory, Asst. Prof. Dr. Ayca Z. İlter Tataroğlu is working on personalised treatment methods for leukaemia.
Working on new generation cellular therapy, Asst. Prof. Dr. Ayca Z. İlter Tataroğlu; ‘In fact, we aim to develop a treatment method to turn the immune system cells we obtain from patients into “fighter” cells that specifically recognise cancer cells and return them to the patient. We are carrying out the project in cooperation with Liv Hospital Vadistanbul and Virostem Biotechnology. In the study we have developed, we aim to produce fighter cells in purity that can be given to patients at the clinical level.’
The World Health Organisation noted that by 2030, they aim to increase the survival rate of childhood cancer survivors in the world to at least 60 percent.